vimarsana.com

Latest Breaking News On - Richardj mark - Page 6 : vimarsana.com

Sempra (NYSE:SRE) Shares Sold by Quadrant Capital Group LLC

Quadrant Capital Group LLC cut its holdings in Sempra (NYSE:SRE – Free Report) by 3.7% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 6,387 shares of the utilities provider’s stock after selling 243 shares during the period. Quadrant Capital Group LLC’s holdings in Sempra were […]

Canada
United-states
Trevori-mihalik
Richardj-mark
Quadrant-capital-group
Royal-bank
Mechanics-bank-trust-department
Sandy-spring-bank
Morgan-stanley
Wells-fargo-company
Securities-exchange-commission

Truist Financial Reiterates "Buy" Rating for Tenet Healthcare (NYSE:THC)

Truist Financial reaffirmed their buy rating on shares of Tenet Healthcare (NYSE:THC – Free Report) in a report published on Wednesday, Benzinga reports. They currently have a $130.00 target price on the stock, up from their prior target price of $120.00. A number of other brokerages also recently commented on THC. Wells Fargo & Company […]

Canada
United-states
Richardw-fisher
Richardj-mark
Mirae-asset-global-investments-co
Wells-fargo-company
Summerhaven-investment-management
Tenet-healthcare
Violich-capital-management-inc
Royal-bank
Securities-exchange-commission

Royal Bank of Canada Raises Tenet Healthcare (NYSE:THC) Price Target to $136.00

Tenet Healthcare (NYSE:THC – Free Report) had its target price lifted by Royal Bank of Canada from $109.00 to $136.00 in a report released on Wednesday morning, Benzinga reports. Royal Bank of Canada currently has an outperform rating on the stock. THC has been the subject of a number of other reports. UBS Group upped […]

United-states
Canada
Richardj-mark
Securities-exchange-commission
Tenet-healthcare
Royal-bank
Bleakley-financial-group
Tenet-healthcare-corporation
Vanguard-group-inc
First-eagle-investment-management
Tenet-healthcare-company-profile

Tenet Healthcare (NYSE:THC) Given Buy Rating at Mizuho

Mizuho reissued their buy rating on shares of Tenet Healthcare (NYSE:THC – Free Report) in a report released on Wednesday, Benzinga reports. The brokerage currently has a $130.00 price target on the stock, up from their previous price target of $118.00. A number of other analysts also recently weighed in on THC. Stephens increased their […]

United-states
Richardj-mark
Paolam-arbour
Sunbelt-securities-inc
Rise-advisors
Fintrust-capital-advisors
Cantor-fitzgerald
Securities-exchange-commission
Tenet-healthcare-corporation
Tenet-healthcare-company-profile
Tenet-healthcare

Tenet Healthcare's (THC) "Buy" Rating Reaffirmed at Mizuho

Mizuho restated their buy rating on shares of Tenet Healthcare (NYSE:THC – Free Report) in a research report sent to investors on Wednesday, Benzinga reports. Mizuho currently has a $130.00 target price on the stock, up from their prior target price of $118.00. Several other research analysts have also issued reports on the company. Wolfe […]

Canada
United-states
Richardw-fisher
Richardj-mark
Knots-management
Cantor-fitzgerald
Royal-bank
Norges-bank
Glenview-capital-management
Barclays
Tenet-healthcare

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.